Sponsored by Knice Solutions
How to Involve Patients in Your Clinical Trial Solutions
Patients are at the center of clinical trials, but often left out of the entire trial design process. Partnering with patients early and incorporating their voice in solution development not only enhances the patient experience, but also increases engagement and retention rates. Join us in an interactive workshop to learn how easy it is to infuse the patient perspective into your next solution offering.
Alica C. Staley, MBA, Vice President, Patient Engagement, Medidata Solutions
Kelly McKee, MA, Vice President, Patient Registries and Recruitment, Medidata Solutions
Anne Marie Mercurio, Patient Advocate
Decentralizing Clinical Trials: What have we learned, what do we want to keep, what do we want to change?
As sites, CRO’s and sponsors adapted at speed to find methods to ensure patient safety and continuity of clinical research during the medical emergency we now must take time to reflect. Decentralizing clinical trials must meet the needs of patients, sites and sponsors. To be successful, the industry and sites must work together to harness experience and expertise, defining best practice and increasing optionality and inclusivity of clinical research as a choice for all.
Join Syneos Health Decentralized Solutions team to learn how to adopt DCT technologies and methodologies that work for sites, patients and sponsors.
Scott Scarola, VP of DCT Operations, Syneos
Marie Emms, VP Site & Patient Access, Syneos
Lisa Kodis, MSN, RN, Associate Director of Research Nursing, Illingworth Research
Achieving Diversity, Equity and Inclusion in Clinical Trial Enrollment
To achieve health equity, it is critical that clinical trials are inclusive of the populations that will ultimately use the medicine or therapy. In this interactive session, presenters from Janssen, the Pharmaceutical Companies of Johnson & Johnson, will share best practices for ensuring diverse and inclusive enrollment in clinical trials through close collaboration with trial sites, operational excellence in trial design and, most importantly, building trust in clinical research in local communities.
Ramona Burress, MBA, PharmD, Associated Director, Diversity & Inclusion in Clinical Trials, Janssen
Luis Arroyo, Specialist, Diversity & Inclusion in Clinical Trials, Janssen
Post-Pandemic Trends Here to Stay
The pandemic irrevocably scrambled the clinical trial operating model, accelerating a number of trends. These trends include more decentralized, direct-to-patient elements, such as remote monitoring and increased reliance on digital marketing for patient recruitment. Sites that succeed will be those that adopt flexible, technology-centered practices to adapt to these changes. In this session, speakers will advise sites on best practices, sharing a case study and integrating results from a recent site survey.
Raymond Nomizu, CEO, CRIO
Jessica Branning, CEO & Founder, Clincloud